Vesta Announces First Quarter 2025 Earnings Conference Call and Webcast
MEXICO CITY--(BUSINESS WIRE)-- Corporación Inmobiliaria Vesta, S.A.B. de C.V. (NYSE: VTMX, BMV: VESTA) ("Vesta") announced today that the Company's first quarter 2025 financial results will be released after market close on Wednesday, April 23, 2025. Vesta will host a conference call to discuss its results:
THURSDAY, APRIL 24, 2025
11:00 a.m. ET
9:00 a.m. Mexico City Time
To participate in the conference call, please connect via webcast or by dialing:
International Toll-Free: |
+1 (888) 350-3870 |
International Toll: |
+1 (646) 960-0308 |
International Numbers: |
|
Participant Code: |
1849111 |
Webcast: |
The call replay will be available for one week following the conference call and can be accessed two hours after the call’s completion via Vesta’s IR website, along with the company's earnings press release, financial tables, and slide presentation.
About Vesta
Vesta is a real estate owner, developer and asset manager of industrial buildings and distribution centers in Mexico. As of December 31, 2024, Vesta owned 224 properties located in modern industrial parks in 16 states of Mexico totaling a GLA of 40.3 million sf (3.7 million m2). Vesta has several world-class clients participating in a variety of industries such as automotive, aerospace, retail, high-tech, pharmaceuticals, electronics, food and beverage and packaging. For additional information visit: www.vesta.com.mx.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250403019890/en/
Investor Relations Contact in Mexico:
Juan Sottil, CFO
[email protected]
Tel: +52 55 5950-0070 ext. 133
Fernanda Bettinger, IRO
[email protected]
[email protected]
Tel: +52 55 5950-0070 ext. 163
In New York:
Barbara Cano
[email protected]
Tel: +1 646-452-2334
Source: Corporación Inmobiliaria Vesta, S.A.B. de C.V.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FairJourney Bio Delivers Antibody Engineering for Novel Tumor-Conditional IL-12 Therapeutic Approach That Unlocks the Potential of Localized Cytokine Activation
- TJX stock drops as profit outlook falls short of analyst estimates
- ICG: Oxy Capital Comments on the Half-Year Results of Irish Continental Group PLC (“ICG”) and the Independent Board’s Response to Its Letter
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share